# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000882095-24-000007
Filing Date
2024-02-23
Accepted
2024-02-23 16:44:27
Documents
125
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | gild-20231231.htm iXBRL | 10-K | 3213497
2 | EXHIBIT 21.1 LISTING OF SUBSIDIARIES | gild2023form10-kexhibit211.htm | EX-21.1 | 40028
3 | EXHIBIT 23.1 CONSENT OF INDEPENDANT REGISTERED PUBLIC ACCOUNTING FIRM | gild2023form10-kexhibit231.htm | EX-23.1 | 2758
4 | CEO CERTIFICATION | gild2023form10-kexhibit311.htm | EX-31.1 | 8324
5 | CFO CERTIFICATION | gild2023form10-kexhibit312.htm | EX-31.2 | 8286
6 | SECTION 906 CERTIFICATIONS | gild2023form10-kexhibit32.htm | EX-32 | 4822
7 | COMPENSATION RECOVERY POLICY | gild2023formex971compensat.htm | EX-97.1 | 10903
13 | PERFORMANCE GRAPH | gild-20231231_g1.jpg | GRAPHIC | 49865
| Complete submission text file | 0000882095-24-000007.txt |  | 17690865

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | gild-20231231.xsd | EX-101.SCH | 102438
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | gild-20231231_cal.xml | EX-101.CAL | 166653
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | gild-20231231_def.xml | EX-101.DEF | 584567
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | gild-20231231_lab.xml | EX-101.LAB | 1329777
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | gild-20231231_pre.xml | EX-101.PRE | 926375
127 | EXTRACTED XBRL INSTANCE DOCUMENT | gild-20231231_htm.xml | XML | 3440666

Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19731 | Film No.: 24672123
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)